Fount Bio, Inc.

CAMBRIDGE, MA · Founded 2018 · Medtech · Private

Biopolymer-based hyaluronic acid delivery systems using bioorthogonal chemistry

Claim this profile

Follows are private to you and power your alerts

Updated · fountbio.com

Sector
Medtech
Headquarters
CAMBRIDGE, MA
Founded
2018
Latest Form D
$8.2M, Jul 2021
Total capital
$8.2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$8.2M
1 Form D · last Jul 2021
63 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
12 pending · first 2025
Rank in peer group#23 of 50

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $8.2M1st Form D$8.2M
2021FEDERAL ↑EQUITY ↓Cumulative $8.2M1st Form D$8.2M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$8.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 50 peers

Line = median

Medtech · Material

  • Granted patents#23 · top 46%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Samir MitragotriResearcherDirectorLinked by 1 patent
  • Anthony AiudiDirectorNamed in SEC Form D filings
  • Douglas LevinsonExecutive Officer, DirectorNamed in SEC Form D filings
  • Justin BurnsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 13
  • PendingTransdermal DeliveryUSPTOApplication 18034139
  • PendingCrosslinked MaterialsUSPTOApplication 19188920
  • GrantedCrosslinked MaterialsUSPTOUS 12,311,048
Show all 13 patent records
  • Transdermal DeliveryNov 6, 2025 · Application 18034139Pending
  • Crosslinked MaterialsOct 9, 2025 · Application 19188920Pending
  • Crosslinked MaterialsMay 27, 2025 · US 12,311,048Granted
  • Delivery And Retention Of Active Agents Within The SkinJun 9, 2022 · Application 17602110Pending
  • Transdermal DeliveryApplication 63106623Pending
  • Delivery And Retention Of Active Agents Within The SkinApplication PCTUS2020028639Pending
  • Crosslinked MaterialsApplication PCTUS2019059553Pending
  • Delivery And Retention Of Active Agents Within The SkinApplication 62836402Pending
  • Ophthalmic FilmsApplication 19490453Pending
  • Crosslinked MaterialsApplication 62754995Pending
  • Ophthalmic FilmsApplication PCTUS2024032766Pending
  • Opthalmic FilmsApplication 63507099Pending
  • Transdermal DeliveryApplication PCTUS2021056916Pending
  • Vivex Biomedical, Inc.Similar federal contract value in Medtech · null in contracts
  • SCIENTIFIC INTAKE LTD COSimilar federal contract value in Medtech · null in contracts
  • NOCIRA, LLCSimilar federal contract value in Medtech · null in contracts
  • BlinkTBI, Inc.Similar federal contract value in Medtech · null in contracts
  • EPIWATCH, INC.Similar federal contract value in Medtech · null in contracts
  • Viz.aiSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .